This preliminary exploration results from a discussion with Dr Emanuela Todeva from the University of Surrey, who has previously been involved in network of health clusters in the south of England. Dr Todeva provided a list of pharmaceutical firms that were active in this region. From this list a ‘market network’ was developed identifying the alliance relationships between these selected firms and other pharmaceutical firms, as identified from business reports over the past two years.
